Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF
Clinical trial NCT04554056 · COMPLETED
Trial details
- NCT number
- NCT04554056
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-21
- Primary completion
- 2022-08-20
- Enrollment
- 586
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.